drugset / Trial / NCT03088137

Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment

NCT03088137

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to show equivalence with regard to the number of oocytes retrieved between follitropin alfa (pen-injectors) Primapur® and Gonal-f® in woman undergoing IVF/ICSI

Timeline

Start
2017-02-08
Primary completion
2018-08-17
Completion
2018-08-17

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gonal-f Protein / enzyme biologic 150 iu Subcutaneous

Indications